Т. 14, №4 (56) | Клиническая онкология

Experience of management of breast cancer in pregnant patient of 28–29 weeks of gestation
Authors: Dronova V.L. Dronov O.I. Lyalkin S.A. Mokryk О.М.... Т. 14, №4 (56)

A rare form of renal cell cancer metastasis to the minor salivary gland: a clinical case
Authors: Antoniv R.R. Kostyshyn I.D. Girna G.A. Boyko V.V.... Т. 14, №4 (56)

The impact of tumor burden score on postoperative morbidity and survival in colorectal cancer patients with liver metastases
Authors: Burlaka A. Bezverhnyi V. Mykytyuk A. Dupyk M.... Т. 14, №4 (56)

Peculiarities of treatment of patients with laryngeal cancer
Authors: Lukach E.V. Serezhko Yu.O. Tsymbalyuk E.M. Т. 14, №4 (56)

Cost minimization analysis of neoadjuvant treatment of luminal B HER2/neu-negative breast cancer: chemotherapy versus hormone therapy
Authors: Artemenko M.V. Bondarenko I.M. Zavizion V.F. Avierin D.I. Т. 14, №4 (56)

Conducting mobilization courses and apheresis of CD34⁺. Experience of the Nonprofit Organization National Cancer Institute
Authors: Kryachok I.A. Raіnyk K.P. Shokun N.V. Burtna A.S. Т. 14, №4 (56)

Midazolam in modern anesthesiology and intensive care
Authors: Lisnyy I.I. Zakalska K.A. Т. 14, №4 (56)

Use of artificial intelligence in medicine, surgery, dentistry, and oncology
Authors: Svintsitskyi A.V. Klymova V.V. Sendetskyi S.S. Т. 14, №4 (56)

Advantages and risks of using CDK4/6 inhibitors, including palbociclib, in first-line therapy for HR+ metastatic breast cancer
Т. 14, №4 (56)

KEYNOTE-006 study: results of 10-year follow-up of pembrolizumab versus ipilimumab in advanced melanoma
Т. 14, №4 (56)

Seven-year analysis of adjuvant pembrolizumab versus placebo in stage III melanoma in the EORTC1325 / KEYNOTE-054 trial
Т. 14, №4 (56)

Pembrolizumab vs Placebo as Adjuvant Therapy for High-Risk Stage II Melanoma: Long-Term Follow-Up, Rechallenge, and Crossover in KEYNOTE-716
Т. 14, №4 (56)

CLL in the context of evidence-based medicine: how do international guidelines align with Ukrainian practice?
Authors: Kryachok I.A. Tytorenko I.B. Moroz Y.V. Т. 14, №4 (56)

A Multidisciplinary Approach to Breast Cancer Treatment in Historical Perspective
Т. 14, №4 (56)


Log in Registration Search for: Home Online Publication Current Issue Issue Archive Authors About Information About the Journal Focus and Scope Indexing For Authors Submission Guidelines and Requirements Peer Review Article Processing Charges Copyright and Licensing Policies Editorial Policy Plagiarism Policy Archiving Policy Policy on the Use of Artificial Intelligence (AI) and AI-Supported Technologies Open Access Procedure for the Retraction of Published Articles Ethical Issues Publication Ethics Procedure for Handling Complaints Regarding Ethical Breaches Privacy Statement International Standards and Principles of Operation
Organization of anticancer fight Tumors of the chest cavity Tumors of abdominal organs Tumors of skin, soft tissues, bones Breast tumor Oncogynecology Tumors of the head and neck Oncurology Oncohematology Radiation diagnostics, radiation therapy Experimental studies Magazine online All news	Contents of the journal : Т. 14, №4 (56) A case from practice Experience of management of breast cancer in pregnant patient of 28–29 weeks of gestation Authors: Dronova V.L. Dronov O.I. Lyalkin S.A. Mokryk О.М.... Т. 14, №4 (56) A rare form of renal cell cancer metastasis to the minor salivary gland: a clinical case Authors: Antoniv R.R. Kostyshyn I.D. Girna G.A. Boyko V.V.... Т. 14, №4 (56) Original Articles The impact of tumor burden score on postoperative morbidity and survival in colorectal cancer patients with liver metastases Authors: Burlaka A. Bezverhnyi V. Mykytyuk A. Dupyk M.... Т. 14, №4 (56) Peculiarities of treatment of patients with laryngeal cancer Authors: Lukach E.V. Serezhko Yu.O. Tsymbalyuk E.M. Т. 14, №4 (56) Cost minimization analysis of neoadjuvant treatment of luminal B HER2/neu-negative breast cancer: chemotherapy versus hormone therapy Authors: Artemenko M.V. Bondarenko I.M. Zavizion V.F. Avierin D.I. Т. 14, №4 (56) Conducting mobilization courses and apheresis of CD34⁺. Experience of the Nonprofit Organization National Cancer Institute Authors: Kryachok I.A. Raіnyk K.P. Shokun N.V. Burtna A.S. Т. 14, №4 (56) Review Articles Midazolam in modern anesthesiology and intensive care Authors: Lisnyy I.I. Zakalska K.A. Т. 14, №4 (56) Use of artificial intelligence in medicine, surgery, dentistry, and oncology Authors: Svintsitskyi A.V. Klymova V.V. Sendetskyi S.S. Т. 14, №4 (56) Advantages and risks of using CDK4/6 inhibitors, including palbociclib, in first-line therapy for HR+ metastatic breast cancer Т. 14, №4 (56) KEYNOTE-006 study: results of 10-year follow-up of pembrolizumab versus ipilimumab in advanced melanoma Т. 14, №4 (56) Seven-year analysis of adjuvant pembrolizumab versus placebo in stage III melanoma in the EORTC1325 / KEYNOTE-054 trial Т. 14, №4 (56) Pembrolizumab vs Placebo as Adjuvant Therapy for High-Risk Stage II Melanoma: Long-Term Follow-Up, Rechallenge, and Crossover in KEYNOTE-716 Т. 14, №4 (56) CLL in the context of evidence-based medicine: how do international guidelines align with Ukrainian practice? Authors: Kryachok I.A. Tytorenko I.B. Moroz Y.V. Т. 14, №4 (56) Topical A Multidisciplinary Approach to Breast Cancer Treatment in Historical Perspective Т. 14, №4 (56)
MORION Publishing House Editorial office and publisher: 02140, Kyiv, ave. Bazhana 10A Tel.: 380 (44) 585-97-10 Specialized medical online publication for doctors, pharmacists, pharmacists, medical students and pharmaceutical universities.Disclaimer morion.ua apteka.ua pharmstandart.com.ua compendium.com.ua proximaresearch.com

Magazine online

Contents of the journal : Т. 14, №4 (56)

A case from practice

Original Articles

Review Articles

Topical